Skip to main content

COVID-19 Archives

Pandemic spurs expansion of surgical care for underserved

Oct. 7, 2021—When the COVID-19 pandemic shut down international travel necessary for overseas medical initiatives, Vanderbilt's Rondi Kauffmann, MD, MPH, began brainstorming ways to extend surgical care to those in need much closer to home.

Read more


Boosta-Palooza

Oct. 7, 2021—VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week's Boosta-Palooza event.

Read more


Pediatricians seeing increase in children with MIS-C after latest COVID surge

Oct. 6, 2021—  by Jessica Pasley More than 195 cases of multi-system inflammatory syndrome in children (MIS-C) have been reported statewide since May 2020, according to Tennessee Department of Health data. The number of cases has more than tripled since early February when the Center for Disease Control and Prevention (CDC) showed about 51 cases in Tennessee....

Read more


AstraZeneca seeks emergency approval for COVID-19 antibodies isolated at VUMC

Oct. 5, 2021—Biopharmaceutical company AstraZeneca has requested emergency use authorization (EUA) from the U.S. Food and Drug Administration for a long-acting antibody combination originally developed at Vanderbilt University Medical Center to protect against COVID-19.

Read more


VUMC research contributed to first COVID-19 pill now under review

Oct. 1, 2021—Vanderbilt research helped allow pharmaceutical giant Merck & Co. to authorization for the first oral antiviral pill to treat COVID-19.

Read more


Campaign thanks employees for their dedication to patients and each other

Sep. 29, 2021—Vanderbilt Health has launched a brand communications campaign — called Caregivers Need Care, Too — designed to thank the workforce for their dedication to their patients and to each other during challenging times.

Read more


Meeting a critical need

Sep. 27, 2021—VUMC employees stepped up at last week’s blood drive to help address the current regional and national shortage of blood and blood products driven by the COVID-19 pandemic.

Read more


Rush testifies before Congress on pandemic’s impact on children

Sep. 27, 2021—Vanderbilt's Meg Rush, MD, MMHC, spoke to several members of Congress recently and painted a vivid picture of the toll the virus has taken on children in Tennessee and at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Read more


City of Tullahoma honors staff of Vanderbilt Tullahoma-Harton Hospital for pandemic care efforts

Sep. 24, 2021—The City of Tullahoma presented a proclamation of thanks to the staff of Vanderbilt Tullahoma Harton Hospital for their dedicated effort to care for the community during the COVID-19 pandemic.

Read more


Study tracks smell, taste loss associated with COVID

Sep. 23, 2021—Vanderbilt researchers are studying ways to better evaluate and predict who is at risk of persistent smell and taste loss after COVID-19 infection.

Read more


Rounds: Hard conversations

Sep. 22, 2021—Difficult conversations are a hallmark of medicine. Patients and their families rely on us to share the facts about their illnesses that are sometimes hard to hear. While many clinicians begin to do this while training, our effectiveness in these conversations develops throughout a career. Telling a young mother she has an aggressive cancer or...

Read more


“Ultra-potent” antibody against COVID-19 variants isolated at VUMC

Sep. 22, 2021—A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more